Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 9
Submit an article Journal homepage
62
Views
5
CrossRef citations to date
0
Altmetric
Theme: Demyelinating diseases - Key Paper Evaluation

What happens when natalizumab therapy is stopped?

Stephen M Schaaf The Ohio State University College of Medicine, Columbus, OH 43210, USA; The Ohio State University College of Medicine, Columbus, OH 43210, USA
,
David Pitt The Ohio State University College of Medicine, Columbus, OH 43210, USA; The Ohio State University College of Medicine, Columbus, OH 43210, USA
&
Michael K Racke The Ohio State University College of Medicine, Columbus, OH 43210, USA;[email protected]
Pages 1247-1250 | Published online: 09 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Giovanna Vitaliti, Nassim Matin, Omidreza Tabatabaie, Mario Di Traglia, Piero Pavone, Riccardo Lubrano & Raffaele Falsaperla. (2015) Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children. Expert Review of Neurotherapeutics 15:11, pages 1321-1341.
Read now
Tina Rike Herold, Veronika Jakl, Anno Graser & Kirsten Eibl-Lindner. (2012) Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis. Clinical Ophthalmology 6, pages 1131-1133.
Read now

Articles from other publishers (3)

Afsaneh Shirani & Olaf Stüve. (2018) Natalizumab: Perspectives from the Bench to Bedside. Cold Spring Harbor Perspectives in Medicine 8:12, pages a029066.
Crossref
Afsaneh Shirani & Olaf Stüve. (2017) Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology. The Journal of Immunology 198:4, pages 1381-1386.
Crossref
Mark S. Freedman, Daniel Selchen, Douglas L. Arnold, Alexandre Prat, Brenda Banwell, Michael Yeung, David Morgenthau & Yves Lapierre. (2014) Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40:3, pages 307-323.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.